INTRODUCTION: Major Depressive Disorder (MDD) is a debilitating and multifactorial neuropsychiatric condition that significantly contributes to the global burden of disease. Its clinical spectrum encompasses persistent low mood, anhedonia, cognitive decline, neurovegetative disturbances, and suicidality. This review synthesizes current evidence on the neurovascular, neurochemical, genetic, and psychosocial mechanisms underlying MDD.
METHODS: A narrative review approach was employed, incorporating data from peer-reviewed publications retrieved through systematic searches in biomedical databases. Emphasis was placed on recent findings that elucidate the interplay between neurobiological dysfunction and systemic influences in MDD pathogenesis.
RESULTS: MDD pathophysiology is intricately linked to dysregulation of monoaminergic neurotransmission, aberrant hypothalamic-pituitary-adrenal (HPA) axis activity, and chronic neuroinflammation. Glial cell impairment, particularly involving astrocytes and microglia, disrupts synaptic homeostasis and neurovascular integrity. Genetic analyses estimate a heritability range of 30-50%, with genome-wide association studies identifying susceptibility loci in synaptic and immune pathways. Epigenetic modifications and perturbations of the gut- brain axis modulate vulnerability and progression. Oxidative stress and attenuated neurotrophic signalling, especially involving brain-derived neurotrophic factor (BDNF), further exacerbate neural circuit dysfunction. Sociodemographic determinants, including sex, psychosocial stressors, and socioeconomic adversity, also shape disease onset and trajectory.
DISCUSSION: Although therapeutic modalities exist, limitations in early detection, treatment response, and long-term remission underscore the need for individualized strategies. Emerging approaches integrating epigenetic biomarkers and systems biology hold potential for precision psychiatry.
CONCLUSION: A systems-level, biopsychosocial understanding of MDD is essential to advance targeted, personalized interventions, ultimately improving clinical outcomes in this complex disorder.
